Fundz

Eigen Therapeutics Emerges From Stealth With $7M In Funding To Develop Therapies That Address Cancer Heterogeneity

PRIVATEDec 08, 2022

Round Type

Funding Round

Redwood CityBiotechnologyHealth CareTherapeutics

Investors

Mount Pleasant VenturesAlumni VenturesBuilders VCFirst Round Capital

Description

Eigen Therapeutics, the biotech startup on a mission to make cancer easier to find and eliminate, announced today their launch. They also announced a $7 million seed round led by Josh Kopelman at First Round Capital, with participation from Builders VC, Kevin Mahaffey, Hawktail, Matthew De Silva (founder at Notable Labs), Varsha Rao, Bioverge, Alumni Ventures, Mount Pleasant Ventures, and others.

Quick answer

Eigen raised an undisclosed amount in a Funding Round round, dated December 8, 2022. Investors: Mount Pleasant Ventures, Alumni Ventures, Builders VC and First Round Capital. Eigen is based in Redwood City, California, United States.

How much did Eigen raise?
Eigen raised an undisclosed amount in a Funding Round round on December 8, 2022.
Who invested in Eigen?
Mount Pleasant Ventures, Alumni Ventures, Builders VC and First Round Capital are named as investors in this round.
What does Eigen do?
Eigen is a seed stage biotech on a mission to make therapies that make cancer easier to find and eliminate.
Where is Eigen based and how big is it?
Eigen is based in Redwood City, California, United States. Fundz records about 4 employees.
Who are the decision-makers at Eigen?
Fundz holds 1 contact at Eigen, including the COO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Eigen that raised within 45 days of this round, from Fundz verified event records.

  • ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
  • Repare Therapeutics raised $1.5M (Seed) on January 19, 2023.
  • Diamante Srl raised an undisclosed amount (Seed) on January 17, 2023.
  • MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
  • Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
  • Inotrem raised an undisclosed amount (Funding Round) on January 9, 2023.

Who to call at Eigen, and when

A new round usually means Eigen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eigen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eigen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eigen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eigen

Location

Redwood City, California, United States

About

Eigen is a seed stage biotech on a mission to make therapies that make cancer easier to find and eliminate. Founded by two key contributors to Notable Labs’ pioneering predictive medicine platform, Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment. Eigen was founded in September 2021 and their investors include First Round Capital, Builders VC, Kevin Mahaffey, Hawktail, Matthew De Silva (founder, Notable Labs), Varsha Rao, Bioverge, Alumni Ventures, and Mount Pleasant Ventures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eigen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsOmid, COO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Eigen's next move

See what Strategic adds

Eigen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.